The Latest: CBD and Cannabis

NACS provides weekly CBD and cannabis updates from the United States and around the globe.

February 18, 2019

ALEXANDRIA, Va. – Each week, NACS brings you a round up news and information on cannabis and CBD to help you stay updated on the fast-moving products and their legality.  Here are the topics in the news for the week of Feb. 11 to Feb.15:

U.S. Federal Activity

  • Congress Holds First Hearing on Banking Marijuana. During the course of a hearing convened by the House Financial Services Subcommittee on Consumer Protection and Financial Institutions, federal legislators sought feedback on the discussion draft of the Secure And Fair Enforcement Banking Act of 2019. The bill—which would grant cannabis businesses access to loans, lines of credit, and other banking services, while sheltering financial institutions from prosecution for handling pot-linked money—was largely praised by state regulators and industry representatives, though some expressed concerns with the potential confusion it would cause given cannabis’ current status as a controlled substance under federal law. Either way, this marks a major step for cannabis advocates in the 116th Congress. (Source: APMarijuana Moment

U.S. State & Local Activity

  • Judge Rules Against Arizona Walmart for Firing Employee with Medical Marijuana Card. An Arizona Walmart location terminated an employee in 2016 who held a valid medical-marijuana card after a drug test came back positive. But now a federal judge has ruled that because Walmart could not prove the employee was impaired at work, the company violated the nondiscrimination provision in the Arizona Medical Marijuana Act. (Source: Phoenix New Times)
  • Arkansas Department of Health Issues Warnings on Cannabis. The Arkansas Department of Health issued a public health advisory to warn Arkansans about the risks of harm associated with use of products derived from cannabis, including marijuana and hemp, that claim to benefit health.  (Source: Arkansas Department of Health)
  • Michigan Health Departments Clamp Down on CBD Food and Drink at Restaurants. Despite efforts by local restaurants to add CBD products to their menus, the Detroit Health Department released a statement explaining that “CBD oil . . . is not an approved food additive by the Michigan Department of Agriculture and Rural Development or the Food and Drug Administration  . . . . According to the Michigan Food Law, unapproved food ingredients cannot be added to food that is sold at restaurants.” (Source: Eater Detroit)
  • North Carolina Officials Begin Enforcement Against CBD Products. The North Carolina Department of Agriculture and Consumer Services plans to start sending warning letters to businesses selling CBD-infused food and beverages, making unapproved health claims about CBD, or selling CBD in nutritional supplements in violation of the Food and Drug Administration’s rules. (Source: CBS 17)
  • Utah’s Largest Health Care Provider Opens Door to Writing Cannabis Recommendations to Qualifying Patients. Intermountain Healthcare has given its physicians the all-clear to recommend medical marijuana to qualifying patients, potentially alleviating a bottleneck that had largely stalled the state’s new cannabis program. (Source: Salt Lake Tribune


  • Department Stores Race to Grab a Piece of the CBD Market. Stores like DSW, Neiman Marcus and Barney’s all recently began selling beauty products that feature CBD—the chemical found in cannabis plants, hemp and marijuana—with one beauty buyer deeming them to be the “next big thing in beauty.” (Source: CNN)
  • European Parliament Passes Cannabis Resolution. Following reports about the World Health Organization recommending a rescheduling of cannabis and several of its key components under international drug treaties, the European Parliament voted on Feb. 13 on a resolution that would help advance medical cannabis in the countries that form the European Union. While non-binding, the resolution seeks to incentivize European nations to increase access to medical marijuana, prioritizing scientific research and clinical studies.  (Source: Forbes)